Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

EUROPACE, published by Oxford University Press, stands at the forefront of cardiovascular and physiological research, as evidenced by its prestigious Q1 categorization in both Cardiology and Cardiovascular Medicine and Physiology (medical) for 2023. With an impressive ranking of #39 out of 387 and #14 out of 113 in the relevant Scopus categories, EUROPACE is recognized for its rigorous peer-reviewed articles that significantly contribute to advancing knowledge in heart rhythm disorders and related approaches. The journal has been operational since 1999 and will continue shaping the future of cardiovascular research until 2024, making it a vital resource for researchers, clinicians, and students alike. Through its commitment to disseminating high-quality research, EUROPACE plays a crucial role in enhancing the understanding and treatment of cardiac conditions, thereby influencing clinical practice and improving patient outcomes across the globe.

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.

JACC-Clinical Electrophysiology, published by Elsevier, stands as a leading journal in the fields of Cardiology and Physiology, with an esteemed Q1 ranking in both categories as of 2023. With an ISSN of 2405-500X and E-ISSN 2405-5018, this journal serves as an essential platform for disseminating cutting-edge research, clinical studies, and innovative practices related to electrophysiological aspects of cardiovascular health. Established in 2015, JACC-Clinical Electrophysiology has attracted high-quality submissions, reflected in its strong presence on Scopus, ranking 41st out of 387 in Cardiology and 15th out of 113 in Physiology (medical), placing it in the 89th and 87th percentiles respectively. Though it operates on a subscription model, its commitment to high standards of peer-reviewed scholarship makes it an indispensable resource for researchers, clinicians, and students dedicated to advancing knowledge and practice in electrophysiology and its impact on cardiac care. Join the community of leaders in the field by engaging with the latest findings and discussions published in this prestigious journal.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.